Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Mayank Sharma, Rahul Shah, Apeksha Saraf, Rohit Kumar, Rahul Maheshwari, Kalpana Balakrishnan, Abhinav Nair, Ranvijay Kumar & Piyush Kumar Gupta. (2024) Current advances in the therapeutic potential of nanomedicines for pulmonary disorders. Emergent Materials.
Crossref
Crossref
Chang Peng, Jun Chen, Rui Wu, Haowen Jiang & Jia Li. (2024) Unraveling the complex roles of macrophages in obese adipose tissue: an overview. Frontiers of Medicine.
Crossref
Crossref
Podsawee Mongkolpathumrat, Faprathan Pikwong, Chayanisa Phutiyothin, Onnicha Srisopar, Wannapat Chouyratchakarn, Sasimanas Unnajak, Nitirut Nernpermpisooth & Sarawut Kumphune. (2024) The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications. Heliyon 10:2, pages e24550.
Crossref
Crossref
Faprathan Pikwong, Chayanisa Phutiyothin, Wannapat Chouyratchakarn, Phornsawat Baipaywad, Podsawee Mongkolpathumrat & Sarawut Kumphune. (2023) Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury. Heliyon 9:9, pages e20150.
Crossref
Crossref
Wannapat Chouyratchakarn, Chayanisa Phutiyothin, Fraprathan Pikwong, Tanpong Chaiwarit, Phornsawat Baipaywad & Sarawut Kumphune. (2023) Development of nanoparticles for delivering recombinant human secretory leukocyte protease inhibitor (rhSLPI) for enhancing human osteoblast differentiation. Materials Today: Proceedings.
Crossref
Crossref
Joanne M. Ramsey, Alice McCloskey, Rachel Gaul, Elena Fernandez Fernandez, Louise Sweeney, Catherine M. Greene, Ronan Macloughlin & Sally-Ann Cryan. 2020. Mucosal Delivery of Drugs and Biologics in Nanoparticles. Mucosal Delivery of Drugs and Biologics in Nanoparticles
125
154
.
Thomas Sécher, Alexie Mayor & Nathalie Heuzé-Vourc'h. (2019) Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!. Frontiers in Immunology 10.
Crossref
Crossref
Éanna Forde, Graeme Kelly, Louise Sweeney, Deirdre Fitzgerald-Hughes, Ronan MacLoughlin & Marc Devocelle. (2019) Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis. Pharmaceutics 11:5, pages 239.
Crossref
Crossref
Fakhara Sabir, Rai K. Farooq, Asim.ur.Rehman & Naveed Ahmed. (2019) Monocyte as an Emerging Tool for Targeted Drug Delivery: A Review. Current Pharmaceutical Design 24:44, pages 5296-5312.
Crossref
Crossref
Tarek A. Ahmed, Khalid M. El-Say, Osama A.A. Ahmed & Ahmed S. Zidan. 2018. Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology. Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology
335
395
.
Sebastian P. Hertel, Gerhard Winter & Wolfgang Friess. (2015) Protein stability in pulmonary drug delivery via nebulization. Advanced Drug Delivery Reviews 93, pages 79-94.
Crossref
Crossref
Megan MeyerIlona Jaspers. (2015) Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. American Journal of Physiology-Lung Cellular and Molecular Physiology 308:12, pages L1189-L1201.
Crossref
Crossref
Oliver J. McElvaney, Niamh O’Reilly, Michelle White, Noreen Lacey, Kerstin Pohl, Tanja Gerlza, David A. Bergin, Hilary Kerr, Cormac McCarthy, M. Emmet O’Brien, Tiziana Adage, Andreas J. Kungl, Emer P. Reeves & Noel G. McElvaney. (2015) The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis. Molecular Immunology 63:2, pages 550-558.
Crossref
Crossref
Ibrahim M. El-Sherbiny, Nancy M. El-Baz & Magdi H. Yacoub. (2015) Inhaled nano- and microparticles for drug delivery. Global Cardiology Science and Practice 2015:1, pages 2.
Crossref
Crossref
Sanjay H. Chotirmall, Mazen Al-Alawi, Bojana Mirkovic, Gillian Lavelle, P. Mark Logan, Catherine M. Greene & Noel G. McElvaney. (2013)
Aspergillus
-Associated Airway Disease, Inflammation, and the Innate Immune Response
. BioMed Research International 2013, pages 1-14.
Crossref
Crossref
Emer P. Reeves, Nessa Banville, Dorothy M. Ryan, Niamh O’Reilly, David A. Bergin, Kerstin Pohl, Kevin Molloy, Oliver J. McElvaney, Khalifah Alsaleh, Ahmed Aljorfi, Osama Kandalaft, Eimear O'Flynn, Patrick Geraghty, Shane J. O’Neill & Noel G. McElvaney. (2013) Intracellular Secretory Leukoprotease Inhibitor Modulates Inositol 1,4,5-Triphosphate Generation and Exerts an Anti-Inflammatory Effect on Neutrophils of Individuals with Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. BioMed Research International 2013, pages 1-18.
Crossref
Crossref
Lauren Willis, Don HayesJr.Jr. & Heidi M. Mansour. (2012) Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery. Lung 190:3, pages 251-262.
Crossref
Crossref
David A. Bergin, Killian Hurley, Noel G. McElvaney & Emer P. Reeves. (2012) Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent. Archivum Immunologiae et Therapiae Experimentalis 60:2, pages 81-97.
Crossref
Crossref
Vandana Patravale, Prajakta Dandekar & Ratnesh Jain. 2012. Nanoparticulate Drug Delivery. Nanoparticulate Drug Delivery
1
28
.
Ciara Kelly, Caroline Jefferies & Sally-Ann Cryan. (2011) Targeted Liposomal Drug Delivery to Monocytes and Macrophages. Journal of Drug Delivery 2011, pages 1-11.
Crossref
Crossref
Vanesa Anabella Guazzone, Diego Guerrieri, Patricia Jacobo, Romina Julieta Glisoni, Diego Chiappetta, Livia Lustig & H. Eduardo Chuluyan. (2011) Micro-encapsulated secretory leukocyte protease inhibitor decreases cell-mediated immune response in autoimmune orchitis. Life Sciences 89:3-4, pages 100-106.
Crossref
Crossref
Mariana Kasabova, Ahlame Saidi, Clément Naudin, Juliette Sage, Fabien Lecaille & Gilles Lalmanach. (2011) Cysteine Cathepsins: Markers and Therapy Targets in Lung Disorders. Clinical Reviews in Bone and Mineral Metabolism 9:2, pages 148-161.
Crossref
Crossref
Elaine Hayes, Kerstin Pohl, Noel G. McElvaney & Emer P. Reeves. (2011) The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell. Archivum Immunologiae et Therapiae Experimentalis 59:2, pages 97-112.
Crossref
Crossref
Ibrahim M. El-Sherbiny, Diana G. Villanueva, Dea Herrera & Hugh D. C. Smyth. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
101
126
.
Aileen Gibbons & Hugh D. C. Smyth. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
223
236
.
Aileen Gibbons, Noel G. McElvaney & Sally-Ann Cryan. (2010) A Dry Powder Formulation of Liposome-Encapsulated Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) for Inhalation: Preparation and Characterisation. AAPS PharmSciTech 11:3, pages 1411-1421.
Crossref
Crossref
Sinéad Weldon, Paul McNally, Noel G. McElvaney, J. Stuart Elborn, Danny F. McAuley, Julien Wartelle, Abderrazzaq Belaaouaj, Rodney L. Levine & Clifford C. Taggart. (2009)
Decreased Levels of Secretory Leucoprotease Inhibitor in the
Pseudomonas
-Infected Cystic Fibrosis Lung Are Due to Neutrophil Elastase Degradation
. The Journal of Immunology 183:12, pages 8148-8156.
Crossref
Crossref